Quick Answer
Medicus Pharma Ltd. reported Net Income of -$47.28 million for fiscal year 2025.
Medicus Pharma Ltd. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net Income | -$47.28M -323.8% |
-$11.16M -109.9% |
-$5.31M | — |
| Diluted EPS | -$2.74 -136.2% |
-$1.16 +24.2% |
-$1.53 | — |
| Total Assets | $10.06M +78.2% |
$5.65M +198.3% |
$1.89M | — |
| Cash and Equivalents | $8.71M +109.0% |
$4.16M +142.2% |
$1.72M | — |
| Stockholders Equity | -$67.6K -102.2% |
$3.13M +182.0% |
$1.11M +109.1% |
-$12.19M |
| R&D Expense | $7.72M +118.9% |
$3.53M +1722.4% |
$193.6K | — |
| Operating Income | -$34.36M -207.3% |
-$11.18M -136.4% |
-$4.73M | — |
| Shares Outstanding | 25.18M +132.1% |
10.85M +34.3% |
8.08M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$20.94M | -818.7% | -310.3% |
| Diluted EPS | September 30, 2025 | -$1.12 | -366.7% | -160.5% |
| Total Assets | September 30, 2025 | $9.98M | — | -16.4% |
| Cash and Equivalents | September 30, 2025 | $8.66M | — | -10.4% |
| Stockholders Equity | September 30, 2025 | -$910.1K | -119.0% | -128.0% |
| R&D Expense | September 30, 2025 | $1.68M | +198.6% | +17.0% |
| Operating Income | September 30, 2025 | -$15.00 | +100.0% | +100.0% |
| Shares Outstanding | September 30, 2025 | 20.97M | — | +31.6% |
- Medicus Pharma Ltd. reported Net Income of -$47.28 million for fiscal year 2025.
- Medicus Pharma Ltd. showed a decrease of -323.8% in Net Income compared to the prior fiscal year.
- Medicus Pharma Ltd. reported Diluted EPS of $2.74 per share (loss) for fiscal year 2025.
- Medicus Pharma Ltd. showed a decrease of -136.2% in Diluted EPS compared to the prior fiscal year.
- Medicus Pharma Ltd. reported Total Assets of $10.06 million for fiscal year 2025.
- Medicus Pharma Ltd. showed an increase of +78.2% in Total Assets compared to the prior fiscal year.
- Medicus Pharma Ltd. reported Cash and Equivalents of $8.71 million for fiscal year 2025.
- Medicus Pharma Ltd. showed an increase of +109.0% in Cash and Equivalents compared to the prior fiscal year.
- Medicus Pharma Ltd. reported Stockholders Equity of -$67.6 thousand for fiscal year 2025.
- Medicus Pharma Ltd. showed a decrease of -102.2% in Stockholders Equity compared to the prior fiscal year.
- Medicus Pharma Ltd. reported R&D Expense of $7.72 million for fiscal year 2025.
- Medicus Pharma Ltd. showed an increase of +118.9% in R&D Expense compared to the prior fiscal year.
- Medicus Pharma Ltd. reported Operating Income of -$34.36 million for fiscal year 2025.
- Medicus Pharma Ltd. showed a decrease of -207.3% in Operating Income compared to the prior fiscal year.
- Medicus Pharma Ltd. reported Shares Outstanding of 25.18 million shares for fiscal year 2025.
- Medicus Pharma Ltd. showed an increase of +113.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: